Skip to content
- BRCA1 promoter methylation in breast cancer patients is associated with response to olaparib/eribulin combination therapy.
- Kawachi A, Yamashita S, Okochi-Takada E, Hirakawa A, Tsuda H, Shimomura A, Kojima Y, Yonemori K, Fujiwara Y, Kinoshita T, Ushijima T, Tamura K.
- Breast Cancer Res Treat. 2020 Apr 20. doi: 10.1007/s10549-020-05647-w. [Epub ahead of print]
- Gene-to-gene interactions and the association of TP53, XRCC1, TNFa, HMMR, MDM2 and PALB2 with breast cancer in Kyrgyz females.
- Isakova JT, Vinnikov D, Kipen VN, Talaibekova ET, Aldashev AA, Aldasheva NM, Makieva KB, Semetei Kyzy A, Bukuev NM, Tilekov EA, Shaimbetov BO, Kudaibergenova IO.
- Breast Cancer. 2020 Apr 15. doi: 10.1007/s12282-020-01092-1. [Epub ahead of print]
- Bilateral Paget's Disease of the Breast in a Patient with CHEK2 Mutation.
- Owusu-Brackett N, Menon PD, Nazarullah A, Jatoi I, Elmi M.
- Eur J Breast Health. 2020 Apr 1;16(2):152-154. doi: 10.5152/ejbh.2020.5568. eCollection 2020 Apr.